Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,266 signal articles · 42 in last 24h · 115,320 total before filter · latest 36m ago
42last 24h
1799last 7d
300● bullish (7d)
170● bearish (7d)
205publishers
AllMacro320Earnings844M&A103Regulatory25Product16Analyst25
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
BioStem Technologies Q2 Earnings Call Highlights
MarketBeat2d agoneutral
BioStem Technologies Q2 Earnings Call Highlights

BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from $6.1 million in the first quarter, supported by higher hospital sales, expanded commercial coverage

Spire Global Q2 Earnings Call Highlights
MarketBeat2d agoneutral
Spire Global Q2 Earnings Call Highlights

Spire Global (NYSE:SPIR) reported second-quarter revenue of $18 million and reaffirmed its 2026 revenue outlook of $75 million to $85 million, as the satellite-data company cited growing government weather, radio frequency geolocation and international defense opportunities. Chief Executive Officer

Nebius stock quietly defies its own history after earnings
TheStreet3d agoneutral
Nebius stock quietly defies its own history after earnings

Nebius Group (NBIS) has trained its investors to brace for disappointment on days when the headlines look strong. In May, the company reported blowout first-quarter results, only to watch its stock fall almost 9% the following Monday. That pattern is exactly why the reaction stood out on Wednesday, ...